A pivotal phase III trial investigating adjuvant colorectal cancer vaccine [OncoVAX; Intracel] in patients with stage II colorectal cancer.

Trial Profile

A pivotal phase III trial investigating adjuvant colorectal cancer vaccine [OncoVAX; Intracel] in patients with stage II colorectal cancer.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Aug 2014

At a glance

  • Drugs Colorectal cancer vaccine-Vaccinogen (Primary)
  • Indications Colorectal cancer
  • Focus Registrational; Therapeutic Use
  • Sponsors Intracel Corporation
  • Most Recent Events

    • 09 Nov 2010 This trial is expected to start before the end of 2010, according to a Vaccinogen media release.
    • 08 Mar 2010 Status changed from planning to not yet recruiting, according to Vaccinogen.
    • 04 May 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top